Support your diagnostic and treatment decisions with state-of-the-art genomic testing.
Support your diagnostic and treatment decisions with state-of-the-art genomic testing.
Genomic testing is vital
Gliolab offers a clinically-validated CLIA-certified testing platform to support the diagnosis and treatment of glioblastoma. Our tests provide critical molecular insights with quick turnaround times.
Our Different Testing Options:
We offer three testing options to help guide a treatment plan that is just right for your patients.
TESTS WE OFFER
TEST NAME
PURPOSE
- Confirms diagnosis; determines MGMT methylation; detects CNAs in 29 genes
- Detects mutations, CNAs, TMB, MSI across 523 genes
- Identifies known and novel gene fusion partners of 137 genes (e.g., FGFR3-TACC3, NTRK, ALK)
- Confirms diagnosis; determines MGMT methylation; detects CNAs in 29 genes
- Detects mutations, CNAs, TMB, MSI across 523 genes
- Identifies known and novel gene fusion partners of 137 genes (e.g., FGFR3-TACC3, NTRK, ALK)
Why is genomic testing essential in glioblastoma?
WHO 2021 CNS Classification Molecular Mandate
IDH-wildtype status and specific
molecular markers are now required to confirm
a glioblastoma diagnosis. Beyond diagnosis,
genomic testing informs:
- Selection of targeted therapies
- MGMT-based chemotherapeutic decisions
- Eligibility for biomarker-driven trials
- Patient counseling and prognostication
Gliolab provides cutting-edge, CLIA-certified
testing services that enable full genomic
characterization of glioblastoma tumors with
quick turnaround times.
Clinical scenarios where testing should be ordered
- Initial characterization of newly diagnosed glioblastoma
- Identifies glioblastoma molecular subtypes
- Essential for challenging diagnosis
- Standardization of MGMT methylation assessment
- Copy number variations in 29 brain tumor-specific genes
Sample requirements and turnaround
Requirements
DETAILS
| Sample Type | 8-10 FFPE scrolls or 10-20 unstained slides (1 H&E slide) |
| Turnaround Time | 10-14 business days from sample receipt |
| Reporting | Sent via secure portal or encrypted email (PDF format) |
| Insurance | Covered by Medicare and major insurers (filed by Gliolab) |
